AI assistant
Avidity Biosciences, Inc. — Director's Dealing 2021
May 20, 2021
30894_dirs_2021-05-20_b08a4254-454c-4968-abc5-cba9aa20a9eb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2021-05-11
Reporting Person: McCarthy Teresa (Chief Human Resources Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $29.00 | 2030-08-23 | Common Stock (106000) | Direct | |
| Stock Option (Right to Buy) | $22.34 | 2031-02-01 | Common Stock (110000) | Direct |
Footnotes
F1: 25% of the shares subject to the option shall vest on August 24, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F2: 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of January 1, 2021 (the "Vesting Commencement Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.